261G000782 - MARALIXIBAT 9,5 MG/ ML FR 30 ML SOL ORAL
TED · 504260-2026Award noticeawardedNo deadline given
Value
Estimated€932,813 · 932,813.31 EUR
Awarded€932,813 · 932,813.31 EUR
WinnerCencora 3Pl Portugal
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 17 | — | 2026-07-21 |
| GILEAD SCIENCES, LDA | 16 | — | 2026-07-21 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 11 | €1,569,649 | 2026-07-14 |
| NOVARTIS FARMA - PROD.FARM SA | 9 | — | 2026-06-30 |
| AMGEN BIOFARMACEUTICA, LDA | 8 | €396,644 | 2026-06-24 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33610000 Medical equipment & pharmaceuticalsDescription
MARALIXIBAT 9,5 MG/ ML FR 30 ML SOL ORAL
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-20 | Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-05-12 | 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-07-07 | 2025/1303 - ISATUXIMAB [20 MG/ML 25 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-05 | 261G000236 - NATALIzumab INJ 20MG/ML AMP 15 ML | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-02 | 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-05-05 | 261G000341 - AVACOPANO 10 MG CAPS | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |